(Q37397149)

20 August 2017

Evaluation of the mu and kappa opioid actions of butorphanol in humans through differential naltrexone blockade (English)

1 reference

20 August 2017

0 references

0 references

S L Walsh

1

1 reference

20 August 2017

A E Chausmer

series ordinal

2

1 reference

20 August 2017

E C Strain

series ordinal

3

1 reference

20 August 2017

G E Bigelow

series ordinal

4

1 reference

20 August 2017

2 October 2007

1 reference

20 August 2017

1 reference

20 August 2017

196

1 reference

20 August 2017

1

1 reference

20 August 2017

143-155

1 reference

Post-marketing experience with an opioid nasal spray for migraine: lessons for the future

20 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2766188

Butorphanol: effects of a prototypical agonist-antagonist analgesic on kappa-opioid receptors

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2766188

Activation profiles of opioid ligands in HEK cells expressing delta opioid receptors.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2766188

Enadoline, a selective kappa opioid agonist: comparison with butorphanol and hydromorphone in humans

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2766188

Differentiation of kappa opioid agonist-induced antinociception by naltrexone apparent pA2 analysis in rhesus monkeys

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2766188

Activation of the cloned human kappa opioid receptor by agonists enhances [35S]GTPgammaS binding to membranes: determination of potencies and efficacies of ligands.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2766188

Transnasal butorphanol. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in acute pain management

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2766188

CI-977, a novel and selective agonist for the kappa-opioid receptor

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2766188

The pharmacology of butorphanol, a 3,14-dihydroxymorphinan narcotic antagonist analgesic

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2766188

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2766188

Sympathetic skin response

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2766188

Butorphanol: a review of its pharmacological properties and therapeutic efficacy

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2766188

Characterization of opioid agonist efficacy in a C6 glioma cell line expressing the mu opioid receptor.

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2766188

Diuresis and suppression of vasopressin by kappa opioids: comparison with mu and delta opioids and clonidine

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2766188

Methods for evaluating addiction liability. (A) "Attitude" of opiate addicts toward opiate-like drugs. (B) a short-term "direct" addiction test.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2766188

Effects of naltrexone on response to intravenous cocaine, hydromorphone and their combination in humans.

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2766188

Evidence that nalorphine, butorphanol and oxilorphan are partial agonists at a κ-opioid receptor

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2766188

Studies on the nature and mechanism of the diuretic activity of the opioid analgesic ethylketocyclazocine

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2766188

Human psychopharmacology of ketocyclazocine as compared with cyclazocine, morphine and placebo

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2766188

Duration of occupancy of opiate receptors by naltrexone

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2766188

Comparison of the sedative effects of butorphanol and midazolam.

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2766188

Discrimination of butorphanol and nalbuphine in opioid-dependent humans

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2766188

Mechanism of diuretic action of spiradoline (U-62066E)-a kappa opioid receptor agonist in the human

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2766188

Discrimination of agonist-antagonist opioids in humans trained on a two-choice saline-hydromorphone discrimination

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2766188

Studies on lysergic acid diethylamide (LSD-25). I. Effects in former morphine addicts and development of tolerance during chronic intoxication.

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2766188

Agonist/antagonist properties of nalbuphine, butorphanol and (-)-pentazocine in male vs. female rats

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2766188

Effects of agonist-antagonist opioids in humans trained in a hydromorphone/not hydromorphone discrimination.

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2766188

Butorphanol agonist effects and acute physical dependence in opioid abusers: comparison with morphine

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2766188

Kappa opioid-induced diuresis in female vs. male rats

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2766188

Synthesis, opioid receptor binding, and biological activities of naltrexone-derived pyrido- and pyrimidomorphinans

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2766188

kappa-Opioid receptor effects of butorphanol in rhesus monkeys

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2766188

Comparing the subjective, psychomotor and physiological effects of intravenous butorphanol and morphine in healthy volunteers.

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2766188

Differential naltrexone antagonism of hydromorphone and pentazocine effects in human volunteers.

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2766188

U-50,488: a selective and structurally novel non-Mu (kappa) opioid agonist

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2766188

Diuretic actions in man of a selective kappa opioid agonist: U-62,066E.

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2766188

Drug discrimination in human postaddicts: agonist-antagonist opioids.

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2766188

Butorphanol: characterization of agonist and antagonist effects in rhesus monkeys

2 September 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/17909753

12 December 2020

inferred from PubMed ID database lookup

Comparative pharmacological and biochemical studies between butorphanol and morphine

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/17909753

12 December 2020

inferred from PubMed ID database lookup

Physiologic, subjective, and behavioral effects of amphetamine, methamphetamine, ephedrine, phenmetrazine, and methylphenidate in man

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/17909753

12 December 2020

inferred from PubMed ID database lookup

Identifiers

DOI

10.1007/S00213-007-0948-Z

1 reference

release_2a5ikqknsfggzmvosrz6c7bkpm

20 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/2a5ikqknsfggzmvosrz6c7bkpm

24 November 2022

mapped directly with Wikidata item

1 reference

20 August 2017

PubMed publication ID

17909753

1 reference